{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:05:31Z","timestamp":1770494731192,"version":"3.49.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Schleswig-Holstein Excellence-Chair Program from the State of Schleswig Holstein"},{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["EXC 2167"],"award-info":[{"award-number":["EXC 2167"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["DFG LU 877\/25-1"],"award-info":[{"award-number":["DFG LU 877\/25-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease characterized by intense itch, and impacting heavily on patients\u2019 and caregivers\u2019 quality of life. Its clinical presentation is accompanied by a variety of comorbidities associated with type 2 inflammation, such as asthma, hay fever and food allergies. However, current data on cardiovascular comorbidities are inconsistent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To identify the risk of cardiovascular diseases (CVDs) in patients with AD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data from electronic health records of 1 070 965 patients with AD and equally distributed propensity-score matched controls were retrieved from the US Collaborative Network, part of the federated TriNetX network. Hazard ratios (HRs) for the risk of onset of CVDs with a prevalence of \u2265 1% in both cohorts within 20 years after diagnosis were determined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 55 CVDs belonging to 8 major cardiovascular groups were identified. Of those, 53 diagnoses displayed a significantly increased risk in patients with AD. Different diagnoses of heart failure and heart disease were found most often, followed by valve insufficiencies, arrhythmia, tachycardia, atrial fibrillation and flutter, but also major adverse cardiovascular events and venous thromboembolism. The highest HRs were displayed by the individual diagnoses of venous insufficiency, atherosclerosis of native arteries of the extremities, and unspecified diastolic (congestive) heart failure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>AD is associated with an increased risk for multiple CVDs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ced\/llae164","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T16:49:05Z","timestamp":1714841345000},"page":"1405-1412","source":"Crossref","is-referenced-by-count":8,"title":["Atopic dermatitis is associated with an increased risk of cardiovascular diseases: a large-scale, propensity-score matched US-based retrospective study"],"prefix":"10.1093","volume":"49","author":[{"given":"Henner","family":"Zirpel","sequence":"first","affiliation":[{"name":"Institute and Comprehensive Centre for Inflammation Medicine, University Hospital Schleswig Holstein (UKSH) , Campus L\u00fcbeck, L\u00fcbeck ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"St\u00e4nder","sequence":"additional","affiliation":[{"name":"Institute and Comprehensive Centre for Inflammation Medicine, University Hospital Schleswig Holstein (UKSH) , Campus L\u00fcbeck, L\u00fcbeck ,","place":["Germany"]},{"name":"Department of Dermatology, Allergology and Venerology, Section for Inflammatory Medicine, UKSH , Campus L\u00fcbeck, L\u00fcbeck ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Fr\u0105czek","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, Collegium Medicum, University Warmia and Mazury in Olsztyn , 10-719 Olsztyn ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0863-7148","authenticated-orcid":false,"given":"Henning","family":"Olbrich","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergology and Venerology, Section for Inflammatory Medicine, UKSH , Campus L\u00fcbeck, L\u00fcbeck ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf J","family":"Ludwig","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergology and Venerology, Section for Inflammatory Medicine, UKSH , Campus L\u00fcbeck, L\u00fcbeck ,","place":["Germany"]},{"name":"L\u00fcbeck Institute of Experimental Dermatology, University of L\u00fcbeck , L\u00fcbeck ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8513-550X","authenticated-orcid":false,"given":"Diamant","family":"Tha\u00e7i","sequence":"additional","affiliation":[{"name":"Institute and Comprehensive Centre for Inflammation Medicine, University Hospital Schleswig Holstein (UKSH) , Campus L\u00fcbeck, L\u00fcbeck ,","place":["Germany"]},{"name":"Department of Dermatology, Allergology and Venerology, Section for Inflammatory Medicine, UKSH , Campus L\u00fcbeck, L\u00fcbeck ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,4]]},"reference":[{"key":"2024102416190634800_llae164-B1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/DERM.0000000000000859","article-title":"Longitudinal course of sleep disturbance and relationship with itch in adult atopic dermatitis in clinical practice","volume":"34","author":"Manjunath","year":"2023","journal-title":"Dermatitis"},{"key":"2024102416190634800_llae164-B2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-3999(03)00572-5","article-title":"The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis","volume":"57","author":"Wittkowski","year":"2004","journal-title":"J Psychosom Res"},{"key":"2024102416190634800_llae164-B3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.mcna.2014.06.009","article-title":"Psychiatric disorders and sleep issues","volume":"98","author":"Sutton","year":"2014","journal-title":"Med Clin North Am"},{"key":"2024102416190634800_llae164-B4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/00015550410023284","article-title":"Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients","volume":"84","author":"Zachariae","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"2024102416190634800_llae164-B5","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.12685","article-title":"Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies","volume":"70","author":"Silverberg","year":"2015","journal-title":"Allergy"},{"key":"2024102416190634800_llae164-B6","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/all.12957","article-title":"Atopic dermatitis is not independently associated with nonfatal myocardial infarction or stroke among US women","volume":"71","author":"Drucker","year":"2016","journal-title":"Allergy"},{"key":"2024102416190634800_llae164-B7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaci.2016.01.015","article-title":"Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients\u00a0with atopic dermatitis","volume":"138","author":"Andersen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2024102416190634800_llae164-B8","doi-asserted-by":"crossref","first-page":"k1786","DOI":"10.1136\/bmj.k1786","article-title":"Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study","volume":"361","author":"Silverwood","year":"2018","journal-title":"BMJ"},{"key":"2024102416190634800_llae164-B9","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jid.2016.11.031","article-title":"Association of atopic dermatitis with cardiovascular risk factors and diseases","volume":"137","author":"Standl","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2024102416190634800_llae164-B10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2133.2002.04717.x","article-title":"Rarity of hypertension in adult patients with atopic dermatitis","volume":"146","author":"Uehara","year":"2002","journal-title":"Br J Dermatol"},{"key":"2024102416190634800_llae164-B11","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1038\/s41598-017-09207-z","article-title":"The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins","volume":"7","author":"Brunner","year":"2017","journal-title":"Sci Rep"},{"key":"2024102416190634800_llae164-B12","doi-asserted-by":"crossref","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"2024102416190634800_llae164-B13","doi-asserted-by":"crossref","first-page":"104639","DOI":"10.1016\/j.ebiom.2023.104639","article-title":"Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study","volume":"93","author":"Olbrich","year":"2023","journal-title":"EBioMedicine"},{"key":"2024102416190634800_llae164-B14","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1111\/jdv.19328","article-title":"Evaluating the risk of infections under interleukin 23 and interleukin 17 inhibitors relative to tumour necrosis factor inhibitors \u2013 a population-based study","volume":"37","author":"Kridin","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024102416190634800_llae164-B15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"2024102416190634800_llae164-B16","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1440-1681.1998.tb02179.x","article-title":"Multiple comparison procedures updated","volume":"25","author":"Ludbrook","year":"1998","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2024102416190634800_llae164-B17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/bmj.310.6973.170","article-title":"Multiple significance tests: the Bonferroni method","volume":"310","author":"Bland","year":"1995","journal-title":"BMJ"},{"key":"2024102416190634800_llae164-B18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamadermatol.2014.3059","article-title":"Central obesity and high blood pressure in pediatric patients with atopic dermatitis","volume":"151","author":"Silverberg","year":"2015","journal-title":"JAMA Dermatol"},{"key":"2024102416190634800_llae164-B19","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/bjd.15727","article-title":"Atopic dermatitis and risk of hypertension, type 2 diabetes, myocardial infarction and stroke in a cross-sectional analysis from the Canadian Partnership for Tomorrow Project","volume":"177","author":"Drucker","year":"2017","journal-title":"Br J Dermatol"},{"key":"2024102416190634800_llae164-B20","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/bjd.16215","article-title":"The association with cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis","volume":"178","author":"Thyssen","year":"2018","journal-title":"Br J Dermatol"},{"key":"2024102416190634800_llae164-B21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/07853890.2013.870018","article-title":"Atopic dermatitis and risk of ischemic stroke: a nationwide population-based study","volume":"46","author":"Su","year":"2014","journal-title":"Ann Med"},{"key":"2024102416190634800_llae164-B22","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.jaip.2023.08.007","article-title":"Incidence of cardiovascular disease and venous thromboembolism in patients with atopic dermatitis","volume":"11","author":"Wan","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102416190634800_llae164-B23","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.jaci.2018.11.030","article-title":"Atopic eczema and major cardiovascular outcomes: a systematic review and meta-analysis of population-based studies","volume":"143","author":"Ascott","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2024102416190634800_llae164-B24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.anai.2018.07.042","article-title":"Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2024102416190634800_llae164-B25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","article-title":"Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2024102416190634800_llae164-B26","doi-asserted-by":"crossref","first-page":"956850","DOI":"10.3389\/fgene.2022.956850","article-title":"Investigating the association of atopic dermatitis with ischemic stroke and coronary heart disease: a Mendelian randomization study","volume":"13","author":"Huang","year":"2022","journal-title":"Front Genet"},{"key":"2024102416190634800_llae164-B27","doi-asserted-by":"crossref","first-page":"868850","DOI":"10.3389\/fcvm.2022.868850","article-title":"Assessing causal associations of atopic dermatitis with heart failure and other cardiovascular outcomes: a Mendelian randomization study","volume":"9","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2024102416190634800_llae164-B28","doi-asserted-by":"crossref","first-page":"e2022165","DOI":"10.5826\/dpc.1204a165","article-title":"Association between atopic dermatitis and major cardiovascular outcomes: a two-sample Mendelian randomization study","volume":"12","author":"Qi","year":"2022","journal-title":"Dermatol Pract Concept"},{"key":"2024102416190634800_llae164-B29","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.amjmed.2015.05.041","article-title":"Increased prevalence of coronary artery disease in severe psoriasis and severe atopic dermatitis","volume":"128","author":"Hjuler","year":"2015","journal-title":"Am J Med"},{"key":"2024102416190634800_llae164-B30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.anai.2019.10.013","article-title":"Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic dermatitis","volume":"124","author":"He","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2024102416190634800_llae164-B31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cytogfr.2015.04.003","article-title":"Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets","volume":"26","author":"Ramji","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"2024102416190634800_llae164-B32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41586-022-04536-0","article-title":"Obesity alters pathology and treatment response in inflammatory disease","volume":"604","author":"Bapat","year":"2022","journal-title":"Nature"},{"key":"2024102416190634800_llae164-B33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00403-021-02240-z","article-title":"Controversial cardiovascular and hematologic comorbidities in atopic dermatitis","volume":"314","author":"Pandher","year":"2022","journal-title":"Arch Dermatol Res"},{"key":"2024102416190634800_llae164-B34","doi-asserted-by":"crossref","first-page":"877638","DOI":"10.3389\/fcvm.2022.877638","article-title":"Association of atopic diseases with atrial fibrillation risk: a systematic review and meta-analysis","volume":"9","author":"Zeng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2024102416190634800_llae164-B35","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.jaad.2019.08.039","article-title":"Atopic dermatitis and risk of atrial fibrillation or flutter: a 35-year follow-up study","volume":"83","author":"Schmidt","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2024102416190634800_llae164-B36","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1016\/j.jaip.2021.04.056","article-title":"Increased risk of atrial fibrillation in patients with atopic triad: a nationwide population-based study","volume":"9","author":"Choi","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102416190634800_llae164-B37","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1253\/circj.CJ-12-1371","article-title":"Pay attention to valvular disease in the presence of atopic dermatitis","volume":"77","author":"Fukunaga","year":"2013","journal-title":"Circ J"},{"key":"2024102416190634800_llae164-B38","first-page":"469","article-title":"Atopic dermatitis as a risk factor for acute native valve endocarditis","volume":"9","author":"Onoda","year":"2000","journal-title":"J Heart Valve Dis"},{"key":"2024102416190634800_llae164-B39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1536\/ihj.17-078","article-title":"Infective endocarditis associated with atopic dermatitis","volume":"59","author":"Aoyagi","year":"2018","journal-title":"Int Heart J"},{"key":"2024102416190634800_llae164-B40","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jaad.2023.12.027","article-title":"Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: a retrospective, observational, comparative cohort study using US claims data","volume":"90","author":"Merola","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"2024102416190634800_llae164-B41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12920-015-0133-x","article-title":"Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways","volume":"8","author":"Ewald","year":"2015","journal-title":"BMC Med Genomics"},{"key":"2024102416190634800_llae164-B42","article-title":"FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions","author":"US Food & Drug Administration"},{"key":"2024102416190634800_llae164-B43","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s13555-021-00587-9","article-title":"The use of real-world data to evaluate the association between atopic dermatitis and cardiovascular disease: a retrospective claims analysis","volume":"11","author":"Wu","year":"2021","journal-title":"Dermatol Ther (Heidelb"},{"key":"2024102416190634800_llae164-B44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/jamadermatol.2023.4090","article-title":"Cardiovascular and venous thromboembolic risk with JAK inhibitors in immune-mediated inflammatory skin diseases: a systematic review and meta-analysis","volume":"160","author":"Ingrassia","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2024102416190634800_llae164-B45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamadermatol.2023.5509","article-title":"Short-term cardiovascular complications in dermatology patients receiving JAK-STAT inhibitors: a meta-analysis of randomized clinical trials","volume":"160","author":"Ireland","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2024102416190634800_llae164-B46","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/bjd\/ljad229","article-title":"Major adverse cardiovascular events in patients with atopic dermatitis treated with oral Janus kinase inhibitors: a systematic review and meta-analysis","volume":"189","author":"Ertus","year":"2023","journal-title":"Br J Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae164\/58694827\/llae164.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/11\/1405\/60035400\/llae164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/11\/1405\/60035400\/llae164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T16:19:36Z","timestamp":1729786776000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/49\/11\/1405\/7664621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,4]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,5,4]]},"published-print":{"date-parts":[[2024,10,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llae164","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,5,4]]}}}